Alkermes plc Profile Avatar - Palmy Investing

Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products …
Biotechnology
IE, Dublin [HQ]

Balance Sheet

14 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
515.00 452.00 1,435.00 1,470.00 1,921.00 1,855.00 1,726.00 1,797.00 1,825.00 1,805.00 1,949.00 2,024.00 1,963.00 2,136.00
Current
407.00 346.00 339.00 408.00 1,047.00 1,019.00 912.00 966.00 1,063.00 1,041.00 1,135.00 1,291.00 1,261.00 1,431.00
Non Current
108.00 106.00 1,096.00 1,061.00 873.00 836.00 813.00 831.00 761.00 764.00 813.00 732.00 702.00 705.00
Liabilities
102.00 60.00 581.00 517.00 524.00 541.00 516.00 594.00 653.00 719.00 882.00 911.00 920.00 933.00
Current
91.00 48.00 89.00 85.00 130.00 236.00 211.00 291.00 339.00 391.00 438.00 471.00 497.00 515.00
Non Current
11.00 12.00 492.00 431.00 393.00 305.00 304.00 303.00 313.00 328.00 444.00 440.00 422.00 417.00
Equity
412.00 392.00 853.00 952.00 1,396.00 1,314.00 1,209.00 1,202.00 1,171.00 1,085.00 1,066.00 1,112.00 1,043.00 1,202.00
Stockholders' Equity
412.00 392.00 853.00 952.00 1,396.00 1,314.00 1,209.00 1,202.00 1,171.00 1,085.00 1,066.00 1,112.00 1,043.00 1,202.00
Retained Earnings
-365.00 -411.00 -524.00 -499.00 -512.00 -739.00 -947.00 -1,044.00 -1,185.00 -1,381.00 -1,492.00 -1,541.00 -1,699.00 -1,343.00
Common Stock
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
-39.00 -45.00 -113.00 24.00 -30.00 -227.00 -208.00 -157.00 -139.00 -196.00 -110.00 -48.00 -158.00 355.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
780.00 805.00 1,380.00 1,453.00 1,910.00 2,056.00 2,159.00 2,249.00 2,358.00 2,467.00 2,559.00 2,655.00 2,752.00 2,547.00
Loss Other Compr. Income
-3.00 -3.00 -2.00 -2.00 -3.00 -3.00 -3.00 -3.00 -3.00 -1.00 -1.00 -3.00 -10.00 -3.00
End of ALKS's Analysis
CIK: 1520262 CUSIP: G01767105 ISIN: IE00B56GVS15 LEI: - UEI: -
Secondary Listings
ALKS has no secondary listings inside our databases.